Copyright
©The Author(s) 2015.
World J Neurol. Mar 28, 2015; 5(1): 17-38
Published online Mar 28, 2015. doi: 10.5316/wjn.v5.i1.17
Published online Mar 28, 2015. doi: 10.5316/wjn.v5.i1.17
Class | Mechanism of action | Generic name (trade name) | Dose range (mg/d) |
Older antidepressants | |||
Mixed serotonin and norepinephrine reuptake inhibitors | |||
First-generation tricyclic antidepressants | Inhibit neuronal reuptake of norepinephrine and serotonin | Amitriptyline (elavil) Clomipramine (anafranil) Doxepin (adapin) Imipramine (tofranil) Trimipramine (surmontil) Protriptyline (vivactil) Lofepramine | 100-300 100-250 100-300 50-300 100-300 75-200 15-60 |
Second-generation tricyclic antidepressants | Inhibit neuronal reuptake of norepinephrine and serotonin | Desipramine (norpramin) Nortriptyline (pamelor) | 100-300 50-150 |
Tetracyclic antidepressants | Inhibit neuronal reuptake of norepinephrine and serotonin | Maprotiline (ludiomil) | 100-200 |
Amoxapine (asendin) | 50-300 | ||
Heterocyclic agents Triazolopyridines | Mixed serotonin effects: Serotonin (5-HT2A) receptor blockade with serotonin reuptake inhibition | Trazodone (desyrel) | 150-400 |
Monoamine oxidase inhibitors | Nonselective inhibitor of monoamine oxidase A and B | Phenelzine (nardil) Tranylcypromine (parnate) Selegiline (eldepryl) | 60-90 20-60 5-10 |
Newer antidepressants | |||
Selective serotonin reuptake inhibitors | Selectively inhibit the reuptake of 5HT at the presynaptic neuronal membrane. Sertraline also markedly inhibits dopamine reuptake | Fluoxetine (prozac) Fluvoxamine (luvox) Paroxetine (paxil) Sertraline (zoloft) Citalopram (celexa) Escitalopram (lexapro) | 20-60 100-300 20-50 50-200 20-40 5-20 |
Serotonin and noradrenaline reuptake Inhibitors | Potent inhibitors of 5HT and norepinephrine uptake; weak inhibitors of dopamine reuptake | Venlafaxine (effexor) Milnacipran (savella) Duloxetine (cymbalta) | 75-350 12.5-100 60 |
Norepinephrine reuptake inhibitors | Noradrenaline reuptake inhibitor. Inhibits norepinephrine reuptake without inhibiting serotonin reuptake | Viloxazine Reboxetine (edronax) Atomoxetine (strattera) | 150-300 4-8 40-80 |
Reversible inhibitors of monoamine oxidase A | Selective, reversible inhibitors of monoamine oxidase A: resulting in increased concentrations of NE, 5-HT, and dopamine in synapse | Moclobemide Brofaromine | 300-600 75-150 |
5HT2 receptor antagonists/reuptake inhibitor serotonin modulators | Mixed serotonin effects. Inhibition of the reuptake of serotonin and selective postsynaptic 5-HT2A blockade | Nefazodone (serzone) Desvenlafaxine (pristiq) Ritanserin | 300-600 50 mg once daily 5-10 |
5HT1a receptor agonists | Partial agonist of serotonin 5-HT1a | Gepirone, ipsapirone, tandospirone, felsinoxan | |
α2-noradrenergic antagonists | Complex action on serotonin and noradrenaline via Serotonin (5-HT2A and 2C) receptor blockade and presynaptic α2-receptor blockade | Mirtazapine (remeron) | 15-45 |
GABA-mimetics | GABAA and GABAB receptor agonists | Fengabine | 900-1800 |
Dopamine reuptake inhibitors | Increases activity of norepinephrine and dopamine only; no significant effect on serotonin | Buproprion (wellbutrin) | 200-450 |
Melatonin receptor agonists | Melatonin MT1 and MT2 receptor agonist and serotonin 5HT2C receptor antagonist | Agomelatine (valdoxan) | 25-50 |
Herbal remedy: Hypericumperforatum/ St. John’s wort | Unclear: inhibits the reuptake of several neurotransmitters, including 5HT, NE, dopamine, and γ-aminobutyric acid | Hypericum perforatum | 300-900 |
- Citation: Abdel-Salam OM. Prevalence, clinical features and treatment of depression in Parkinson’s disease: An update. World J Neurol 2015; 5(1): 17-38
- URL: https://www.wjgnet.com/2218-6212/full/v5/i1/17.htm
- DOI: https://dx.doi.org/10.5316/wjn.v5.i1.17